2012 Q1 Form 10-Q Financial Statement

#000117891312000329 Filed on February 09, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2011 Q4 2010 Q4
Revenue $230.0K $231.00
YoY Change
Cost Of Revenue $6.000K $7.00
YoY Change
Gross Profit $224.0K $224.00
YoY Change
Gross Profit Margin 97.39% 96.97%
Selling, General & Admin $1.920M $1.280M $1.250M
YoY Change 66.96% 2.4% 42.05%
% of Gross Profit 857.14% 571428.57%
Research & Development $3.421M $2.969K $2.186M
YoY Change 59.49% -99.86% 50.76%
% of Gross Profit 1527.23% 1325.45%
Depreciation & Amortization $110.0K $100.0K $70.00K
YoY Change 37.5% 42.86% 40.0%
% of Gross Profit 49.11% 44642.86%
Operating Expenses $4.840M $2.349M $2.824M
YoY Change 79.33% -16.82% 55.16%
Operating Profit -$4.610M -$2.118K -$2.824M
YoY Change 70.8% -99.93%
Interest Expense $440.0K $130.0K $0.00
YoY Change 388.89% -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.170M -$1.990M -$2.820M
YoY Change 59.77% -29.43% 54.1%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.174M -$1.992K -$2.821M
YoY Change 59.74% -99.93% 54.15%
Net Earnings / Revenue -1814.78% -862.34%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.94 -$0.46 -$1.13
COMMON SHARES
Basic Shares Outstanding 44.35M 43.78M
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q1 2011 Q4 2010 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.54M $41.52M $4.740M
YoY Change -11.88% 775.95% 22.16%
Cash & Equivalents $11.61M $6.672K $4.739M
Short-Term Investments $27.94M $34.84M $0.00
Other Short-Term Assets $170.0K $220.0K $60.00K
YoY Change -19.05% 266.67% -14.29%
Inventory
Prepaid Expenses $172.0K $217.0K
Receivables $1.740M $2.110M $740.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $41.46M $43.84M $5.530M
YoY Change -9.13% 692.82% 36.21%
LONG-TERM ASSETS
Property, Plant & Equipment $3.066M $2.883M $1.820M
YoY Change 58.04% 58.41% 45.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $700.0K $1.190M $180.0K
YoY Change 288.89% 561.11% 0.0%
Other Assets $1.155M $1.245M $360.0K
YoY Change 181.71% 245.83% 50.0%
Total Long-Term Assets $5.441M $5.799M $2.350M
YoY Change 115.06% 146.77% 40.72%
TOTAL ASSETS
Total Short-Term Assets $41.46M $43.84M $5.530M
Total Long-Term Assets $5.441M $5.799M $2.350M
Total Assets $46.90M $49.64M $7.880M
YoY Change -2.6% 529.97% 37.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.529M $1.174M $930.0K
YoY Change 19.45% 26.24% 55.0%
Accrued Expenses $230.0K $231.0K $90.00K
YoY Change 109.09% 156.67% 12.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.854M $4.976M $1.480M
YoY Change 154.14% 236.22% 39.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.140M $4.310M $420.0K
YoY Change 728.0% 926.19% 44.83%
Total Long-Term Liabilities $4.141M $4.314M $420.0K
YoY Change 728.2% 927.14% 44.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.854M $4.976M $1.480M
Total Long-Term Liabilities $4.141M $4.314M $420.0K
Total Liabilities $8.995M $9.290M $1.900M
YoY Change 273.24% 388.95% 40.74%
SHAREHOLDERS EQUITY
Retained Earnings -$61.61M -$57.44M
YoY Change
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $37.90M $40.35K $5.980M
YoY Change
Total Liabilities & Shareholders Equity $46.90M $49.64M $7.880M
YoY Change -2.6% 529.97% 37.52%

Cashflow Statement

Concept 2012 Q1 2011 Q4 2010 Q4
OPERATING ACTIVITIES
Net Income -$4.174M -$1.992K -$2.821M
YoY Change 59.74% -99.93% 54.15%
Depreciation, Depletion And Amortization $110.0K $100.0K $70.00K
YoY Change 37.5% 42.86% 40.0%
Cash From Operating Activities -$2.520M -$3.290M -$1.530M
YoY Change 82.61% 115.03% 59.38%
INVESTING ACTIVITIES
Capital Expenditures $310.0K $820.0K $130.0K
YoY Change 181.82% 530.77% 85.71%
Acquisitions
YoY Change
Other Investing Activities $7.780M -$2.940M $500.0K
YoY Change -688.0% -119.92%
Cash From Investing Activities $7.450M -$3.750M $370.0K
YoY Change -6872.73% -1113.51% -114.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 80.00K 4.780M
YoY Change -100.0% -98.33% 71.33%
NET CHANGE
Cash From Operating Activities -2.520M -3.290M -1.530M
Cash From Investing Activities 7.450M -3.750M 370.0K
Cash From Financing Activities 0.000 80.00K 4.780M
Net Change In Cash 4.930M -6.960M 3.620M
YoY Change -87.71% -292.27% -582.67%
FREE CASH FLOW
Cash From Operating Activities -$2.520M -$3.290M -$1.530M
Capital Expenditures $310.0K $820.0K $130.0K
Free Cash Flow -$2.830M -$4.110M -$1.660M
YoY Change 89.93% 147.59% 61.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2011-12-31
dei Document Type
DocumentType
10-Q
CY2010Q4 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
1578000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001158780
CY2012Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44345101
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
PLURISTEM THERAPEUTICS INC
psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
-33000 USD
psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
USD
CY2011 psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
USD
psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
371000 USD
CY2011 psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
3593000 USD
psti Financial Income Expense Net
FinancialIncomeExpenseNet
-35000 USD
psti Financial Income Expense Net
FinancialIncomeExpenseNet
68000 USD
CY2011Q4 psti Financial Income Expense Net
FinancialIncomeExpenseNet
126000 USD
CY2010Q4 psti Financial Income Expense Net
FinancialIncomeExpenseNet
3000 USD
CY2011 psti Financial Income Expense Net
FinancialIncomeExpenseNet
266000 USD
CY2011 psti Issuance Of Common Stock And Warrants Related To February2011 Agreement
IssuanceOfCommonStockAndWarrantsRelatedToFebruary2011Agreement
38142000 USD
CY2011 psti Issuance Of Common Stock And Warrants Related To October2010 Agreement
IssuanceOfCommonStockAndWarrantsRelatedToOctober2010Agreement
5006000 USD
CY2011 psti Issuance Of Common Stock Related To Investors Relation Agreements
IssuanceOfCommonStockRelatedToInvestorsRelationAgreements
155000 USD
psti Issuance Of Shares In Consideration Of Accounts Receivable
IssuanceOfSharesInConsiderationOfAccountsReceivable
USD
psti Issuance Of Shares In Consideration Of Accounts Receivable
IssuanceOfSharesInConsiderationOfAccountsReceivable
243000 USD
CY2011 psti Issuance Of Shares In Consideration Of Accounts Receivable
IssuanceOfSharesInConsiderationOfAccountsReceivable
USD
psti Issuance Of Shares In Consideration Of Leasehold Improvements
IssuanceOfSharesInConsiderationOfLeaseholdImprovements
1245000 USD
psti Issuance Of Shares In Consideration Of Leasehold Improvements
IssuanceOfSharesInConsiderationOfLeaseholdImprovements
USD
CY2011 psti Issuance Of Shares In Consideration Of Leasehold Improvements
IssuanceOfSharesInConsiderationOfLeaseholdImprovements
USD
psti Linkage Differences And Interest On Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnLongTermRestrictedLeaseDeposit
5000 USD
psti Linkage Differences And Interest On Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnLongTermRestrictedLeaseDeposit
-3000 USD
CY2011 psti Linkage Differences And Interest On Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnLongTermRestrictedLeaseDeposit
-4000 USD
psti Linkage Differences And Interest On Short Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortTermRestrictedLeaseDeposit
22000 USD
psti Linkage Differences And Interest On Short Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortTermRestrictedLeaseDeposit
USD
CY2011 psti Linkage Differences And Interest On Short Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortTermRestrictedLeaseDeposit
USD
psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-1921000 USD
psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-1111000 USD
CY2011Q4 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-1902000 USD
CY2010Q4 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-608000 USD
CY2011 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-1682000 USD
psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
121000 USD
psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
73000 USD
CY2011 psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
123000 USD
psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
3923000 USD
psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
2576000 USD
CY2011Q4 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
1074000 USD
CY2011 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
6629000 USD
psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
1904000 USD
psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
1464000 USD
CY2011 psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
3325000 USD
psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
3164000 USD
CY2011 psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
3325000 USD
psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
43225017
psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
22954736
CY2011Q4 psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
43669466
CY2010Q4 psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
24897022
CY2011 psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
31198825
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1174000 USD
CY2011Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1177000 USD
CY2011Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
722000 USD
CY2011Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
633000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
231000 USD
CY2011Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
208000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-134000 USD
CY2011Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97924000 USD
CY2011Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94375000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
USD
CY2011 us-gaap Asset Impairment Charges
AssetImpairmentCharges
11000 USD
CY2011Q4 us-gaap Assets
Assets
49642000 USD
CY2011Q2 us-gaap Assets
Assets
46016000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
43843000 USD
CY2011Q2 us-gaap Assets Current
AssetsCurrent
43297000 USD
CY2011Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
5799000 USD
CY2011Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2719000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6672000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42829000 USD
CY2010Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1583000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4739000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-36157000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3156000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
41246000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44117044
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42443185
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44117044
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42443185
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
USD
CY2011Q2 us-gaap Common Stock Value
CommonStockValue
USD
CY2011Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1926000 USD
CY2011Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
923000 USD
CY2011Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3692000 USD
CY2011Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
USD
CY2011Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
485000 USD
CY2011Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
452000 USD
CY2011Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1186000 USD
CY2011Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
179000 USD
us-gaap Depreciation
Depreciation
199000 USD
us-gaap Depreciation
Depreciation
144000 USD
CY2011 us-gaap Depreciation
Depreciation
312000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.2
CY2011Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2010Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000 USD
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2912000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2002000 USD
CY2011Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1275000 USD
CY2010Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1246000 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4485000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
10000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
7000 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
11000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
254000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
455000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
112000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
34000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
375000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
240000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-15000 USD
CY2011 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-15000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
1926000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
USD
CY2011 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4615000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1960000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-317000 USD
CY2011 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-656000 USD
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
13000 USD
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
-5000 USD
CY2011 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
58000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-97000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
273000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-30273000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
USD
CY2011 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
78000 USD
CY2011 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
155000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49642000 USD
CY2011Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46016000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4976000 USD
CY2011Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2018000 USD
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4314000 USD
CY2011Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
576000 USD
CY2011Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4352000 USD
CY2011Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
USD
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-134000 USD
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
USD
CY2011 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5008000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
47037000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36731000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
367000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
174000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2219000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5755000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6485000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4510000 USD
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
-1992000 USD
CY2010Q4 us-gaap Net Income Loss
NetIncomeLoss
-2821000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-10848000 USD
CY2011Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
1845000 USD
CY2011Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6450000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4578000 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2118000 USD
CY2010Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2824000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-11114000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1245000 USD
CY2011Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
USD
CY2011 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
14000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
996000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
560000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
962000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-134000 USD
CY2011Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2970000 USD
CY2010Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
244000 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
4503000 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
USD
CY2011 us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1011000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
12000 USD
CY2011Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
622000 USD
CY2011Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
576000 USD
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
217000 USD
CY2011Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
314000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5015000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43400000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
400000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
17000 USD
CY2011 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3661000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
50000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
USD
CY2011 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
28000 USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
29000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
2000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
13000 USD
CY2011 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
13000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
898000 USD
CY2011 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
898000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2883000 USD
CY2011Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2088000 USD
CY2011Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
266000 USD
CY2011Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
154000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24000 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5844000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3687000 USD
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2976000 USD
CY2010Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2186000 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8311000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57438000 USD
CY2011Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50953000 USD
us-gaap Revenues
Revenues
385000 USD
us-gaap Revenues
Revenues
USD
CY2011Q4 us-gaap Revenues
Revenues
231000 USD
CY2010Q4 us-gaap Revenues
Revenues
USD
CY2011 us-gaap Revenues
Revenues
USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
30491000 USD
CY2011Q2 us-gaap Short Term Investments
ShortTermInvestments
USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
40352000 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
43422000 USD
CY2010Q2 us-gaap Stockholders Equity
StockholdersEquity
3981000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
68000 USD

Files In Submission

Name View Source Status
0001178913-12-000329-index-headers.html Edgar Link pending
0001178913-12-000329-index.html Edgar Link pending
0001178913-12-000329.txt Edgar Link pending
0001178913-12-000329-xbrl.zip Edgar Link pending
exhibit_10-1.htm Edgar Link pending
exhibit_3-1.htm Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
psti-20111231.xml Edgar Link completed
psti-20111231.xsd Edgar Link pending
psti-20111231_cal.xml Edgar Link unprocessable
psti-20111231_def.xml Edgar Link unprocessable
psti-20111231_lab.xml Edgar Link unprocessable
psti-20111231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk1210981.htm Edgar Link pending